Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 425-220-8
CAS number: 5945-33-5
An Ames test and a chromosome aberration in CHL test were performed on
Fyrolflex BDP. Both in vitro studies were negative in the presence and
absence of metabolic activation. Fyrolflex BDP did not induce any
significant chromosomal damage in the CHL cells. Fyrolflex BDP was not
mutagenic to E. coli or to S. typhimarium. The substance
was also clearly negative in the L5178Y/TK+/- Mouse Lymphoma Mutagenesis
There is no evidence of genotoxic potential of Fyrolflex BDP. Robust
summary for each study is attached in the endpoint of study record.
The substance in not mutagenic.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Questo sito web si avvale di cookie affinché possiate usufruire della migliore esperienza sui nostri siti web.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again